Resp-Ease - Hypertonic sodium chloride
Venture Healthcare Ltd
Description
Mucolytic to facilitate expectoration by reducing sputum viscosity.
4ml nebuliser solution up to twice daily undiluted. It can be used in conjunction with chest hygiene clearance which has been assessed in secondary care.
Indications
Non-CF bronchiectasis for use prior to airway clearance to increase sputum yield, reduce sputum viscosity and increase ease of expectoration.
Complex COPD & complex asthma patients where usual treatment (systemic hydration, physiotherapy, airway clearance, mucolytics/nebulised solutions) are ineffective
Nebulised hypertonic sodium chloride solution (3–7%) is used to mobilise lower respiratory tract secretions in mucous consolidation (e.g. cystic fibrosis).
Nebulised hypertonic sodium chloride solution (3%) is used for mild to moderate acute viral bronchiolitis in infants.
Recipients may benefit from the use of an inhaled bronchodilator before treatment with hypertonic sodium chloride to reduce the risk of temporary irritation, such as coughing, hoarseness, or reversible bronchoconstriction, which may occur.
Preparations Available
Nebuliser solution
Sizes Available
Nebuliser solution
Resp-Ease 3%, 60 × 4 ml
Resp-Ease 6%, 60 × 4 ml
Resp-Ease 7%, 60 × 4 ml
More on: Mucolytics , Hypertonic sodium chloride